KR20050057152A - 원핵 ｄｎａ의 농축 방법 - Google Patents
원핵 ｄｎａ의 농축 방법 Download PDFInfo
- Publication number
- KR20050057152A KR20050057152A KR1020057003719A KR20057003719A KR20050057152A KR 20050057152 A KR20050057152 A KR 20050057152A KR 1020057003719 A KR1020057003719 A KR 1020057003719A KR 20057003719 A KR20057003719 A KR 20057003719A KR 20050057152 A KR20050057152 A KR 20050057152A
- Authority
- KR
- South Korea
- Prior art keywords
- dna
- protein
- polypeptide
- prokaryotic
- prokaryotic dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 69
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 51
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 47
- 229920001184 polypeptide Polymers 0.000 claims abstract description 43
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 43
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 43
- 238000009739 binding Methods 0.000 claims abstract description 15
- 230000027455 binding Effects 0.000 claims abstract description 14
- 108020004414 DNA Proteins 0.000 claims description 123
- 210000001124 body fluid Anatomy 0.000 claims description 21
- 239000010839 body fluid Substances 0.000 claims description 20
- 238000000926 separation method Methods 0.000 claims description 12
- 239000011859 microparticle Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 7
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 101000947157 Homo sapiens CXXC-type zinc finger protein 1 Proteins 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 claims description 4
- 101150038509 TLR9 gene Proteins 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 238000013518 transcription Methods 0.000 claims description 3
- 230000035897 transcription Effects 0.000 claims description 3
- 238000001962 electrophoresis Methods 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 230000002103 transcriptional effect Effects 0.000 claims 1
- 238000001514 detection method Methods 0.000 description 25
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- 244000052769 pathogen Species 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 16
- 230000001717 pathogenic effect Effects 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 9
- 238000002955 isolation Methods 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000007857 nested PCR Methods 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 102100036168 CXXC-type zinc finger protein 1 Human genes 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 108020005202 Viral DNA Proteins 0.000 description 3
- 102000023732 binding proteins Human genes 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000007834 ligase chain reaction Methods 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 2
- 230000004568 DNA-binding Effects 0.000 description 2
- 101710096438 DNA-binding protein Proteins 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000009640 blood culture Methods 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- 101710103504 CXXC-type zinc finger protein 1 Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 101150045515 O gene Proteins 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical group [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150102573 PCR1 gene Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 229920006328 Styrofoam Polymers 0.000 description 1
- 102000008235 Toll-Like Receptor 9 Human genes 0.000 description 1
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- -1 agarose Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009175 antibody therapy Methods 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 239000003302 ferromagnetic material Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 210000004224 pleura Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000005373 porous glass Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008261 styrofoam Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02020904A EP1400589B1 (de) | 2002-09-18 | 2002-09-18 | Verfahren zum Nachweis prokaryontischer DNA |
| EP02020904.5 | 2002-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050057152A true KR20050057152A (ko) | 2005-06-16 |
Family
ID=31896878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057003719A Ceased KR20050057152A (ko) | 2002-09-18 | 2003-08-08 | 원핵 ｄｎａ의 농축 방법 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8062854B2 (enExample) |
| EP (1) | EP1400589B1 (enExample) |
| JP (1) | JP4447459B2 (enExample) |
| KR (1) | KR20050057152A (enExample) |
| CN (1) | CN1681925A (enExample) |
| AT (1) | ATE335816T1 (enExample) |
| AU (1) | AU2003260392A1 (enExample) |
| CA (1) | CA2498951C (enExample) |
| DE (1) | DE50207801D1 (enExample) |
| DK (1) | DK1400589T3 (enExample) |
| ES (1) | ES2266374T3 (enExample) |
| WO (1) | WO2004033683A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE50207801D1 (de) | 2002-09-18 | 2006-09-21 | Sirs Lab Gmbh | Verfahren zum Nachweis prokaryontischer DNA |
| DE102005001889B4 (de) * | 2005-01-14 | 2012-03-29 | Sirs-Lab Gmbh | Verfahren zur Steigerung der Bindungskapazität und -effizienz eines Proteins, das nicht methylierte CPG-Motive enthaltende DNA spezifisch bindet |
| CA2558515C (en) * | 2004-03-05 | 2013-12-03 | Sirs-Lab Gmbh | Method of enriching and/or separating prokaryotic dna by means of a protein which specifically binds dna containing non-methylated cpg motifs |
| GB0413688D0 (en) * | 2004-06-18 | 2004-07-21 | Novartis Forschungsstiftung | Analysis of methylated nucleic acid |
| DE202005009490U1 (de) * | 2005-06-16 | 2006-10-19 | Sirs-Lab Gmbh | Vorrichtung zur Anreicherung/Abtrennung von nicht-methylierte CpG-Motive enthaltender DNA |
| DE102005034628B4 (de) * | 2005-07-19 | 2007-08-23 | Epigenomics Ag | Verfahren zur Untersuchung von Cytosin-Methylierungen in DNA |
| DE102007041864B4 (de) | 2007-09-04 | 2012-05-03 | Sirs-Lab Gmbh | Verfahren zum Nachweis von Bakterien und Pilzen |
| CA2811493C (en) | 2010-09-15 | 2020-06-16 | Spinomix S.A. | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
| US8980553B2 (en) * | 2011-04-02 | 2015-03-17 | New England Biolabs, Inc. | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides |
| US9145580B2 (en) * | 2011-04-02 | 2015-09-29 | New England Biolabs, Inc. | Methods and compositions for enriching either target polynucleotides or non-target polynucleotides from a mixture of target and non-target polynucleotides |
| DE102012219142B4 (de) | 2012-10-19 | 2016-02-25 | Analytik Jena Ag | Verfahren zum Trennen, Erfassen oder Anreichern von unterschiedlichen DNA-Spezies |
| WO2020216966A1 (en) * | 2019-04-26 | 2020-10-29 | Thermo Fisher Scientific Baltics Uab | Isolated nucleic acid binding domains |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| CA2224492A1 (en) | 1995-07-28 | 1997-02-13 | Michael E. T. I. Boerrigter | A method of and test kit for mutagenesis testing |
| AU7680300A (en) | 1999-08-18 | 2001-03-13 | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. | Human dna sequences |
| JP2002034565A (ja) | 2000-07-19 | 2002-02-05 | Japan Science & Technology Corp | 細菌ｄｎａを特異的に認識する受容体タンパク質 |
| DE50207801D1 (de) | 2002-09-18 | 2006-09-21 | Sirs Lab Gmbh | Verfahren zum Nachweis prokaryontischer DNA |
| CA2558515C (en) | 2004-03-05 | 2013-12-03 | Sirs-Lab Gmbh | Method of enriching and/or separating prokaryotic dna by means of a protein which specifically binds dna containing non-methylated cpg motifs |
| GB0423991D0 (en) | 2004-10-29 | 2004-12-01 | Univ Edinburgh | Applications of nucleic acid fragments |
-
2002
- 2002-09-18 DE DE50207801T patent/DE50207801D1/de not_active Expired - Lifetime
- 2002-09-18 ES ES02020904T patent/ES2266374T3/es not_active Expired - Lifetime
- 2002-09-18 DK DK02020904T patent/DK1400589T3/da active
- 2002-09-18 AT AT02020904T patent/ATE335816T1/de active
- 2002-09-18 EP EP02020904A patent/EP1400589B1/de not_active Expired - Lifetime
-
2003
- 2003-08-08 AU AU2003260392A patent/AU2003260392A1/en not_active Abandoned
- 2003-08-08 WO PCT/EP2003/008825 patent/WO2004033683A1/de not_active Ceased
- 2003-08-08 KR KR1020057003719A patent/KR20050057152A/ko not_active Ceased
- 2003-08-08 US US10/528,235 patent/US8062854B2/en not_active Expired - Fee Related
- 2003-08-08 CA CA2498951A patent/CA2498951C/en not_active Expired - Fee Related
- 2003-08-08 CN CNA038222337A patent/CN1681925A/zh active Pending
- 2003-08-08 JP JP2004542300A patent/JP4447459B2/ja not_active Expired - Fee Related
-
2011
- 2011-10-05 US US13/253,661 patent/US8288115B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1681925A (zh) | 2005-10-12 |
| AU2003260392A1 (en) | 2004-05-04 |
| DK1400589T3 (da) | 2006-11-27 |
| ATE335816T1 (de) | 2006-09-15 |
| EP1400589A1 (de) | 2004-03-24 |
| US20100316993A1 (en) | 2010-12-16 |
| JP4447459B2 (ja) | 2010-04-07 |
| EP1400589B1 (de) | 2006-08-09 |
| DE50207801D1 (de) | 2006-09-21 |
| US20120040363A1 (en) | 2012-02-16 |
| CA2498951A1 (en) | 2004-04-22 |
| US8062854B2 (en) | 2011-11-22 |
| JP2005538737A (ja) | 2005-12-22 |
| US8288115B2 (en) | 2012-10-16 |
| ES2266374T3 (es) | 2007-03-01 |
| WO2004033683A1 (de) | 2004-04-22 |
| CA2498951C (en) | 2013-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8288115B2 (en) | Method for enriching a prokaryotic DNA | |
| Pilecky et al. | Pathogen enrichment from human whole blood for the diagnosis of bloodstream infection: prospects and limitations | |
| JP2008054660A (ja) | 核酸を単離するためのろ過装置 | |
| CN108410951B (zh) | 一种新的核酸提取试剂及其应用 | |
| CN116144811B (zh) | 用于检测脑脊液病原的多重引物组、方法和试剂盒 | |
| JPH09327291A (ja) | Ｒｎａの抽出精製方法 | |
| US8481262B2 (en) | Method for enriching and/or separating prokaryotic DNA using a protein that specifically bonds to unmethylated DNA containing CpG-motifs | |
| KR20150127917A (ko) | 자성입자를 이용한 핵산의 추출 및 증폭 방법 | |
| CN110923338A (zh) | 一种能检测多种细菌基因组dna的微阵列芯片及其制备方法 | |
| EP0235727A2 (en) | Rapid dna test for microbes | |
| Berdimuratova et al. | Optimization of PCR purification using silica-coated magnetic beads | |
| EP2171098B1 (en) | Methods for extraction and purification of components of biological samples | |
| US20240025929A1 (en) | Methods and devices for ultrasensitive direct detection of microorganisms | |
| RU2603098C1 (ru) | Способ выделения циркулирующих днк из плазмы или сыворотки крови | |
| JP2022533269A (ja) | 糞便試料中の希少なｄｎａ配列の検出方法 | |
| JP7725453B2 (ja) | 生物試料に由来する微生物ｒｎａの迅速な分離と収集 | |
| JP4519247B2 (ja) | 核酸の抽出精製用試薬 | |
| CN119592714A (zh) | 细菌16s扩增试剂盒、检测方法及应用 | |
| JP2006042743A (ja) | 細菌の回収方法 | |
| JPH11142409A (ja) | 病原性微生物の検出方法 | |
| CN118207301A (zh) | 一种基于带表面尖刺的二氧化硅纳米球高效捕获微量dna联合pcr原位扩增的方法和应用 | |
| HK1101414B (en) | Method of detecting nucleic acid and utilization thereof | |
| HK1101414A1 (en) | Method of detecting nucleic acid and utilization thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20050303 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20080715 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20100712 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20110720 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20100712 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |